Nonclinical safety evaluation of erenumab, a CGRP receptor inhibitor for the prevention of migraine

J Bussiere, R Davies, CH Dean, C Xu, KH Kim, HM Vargas, GJ Chellman, G Balasubramanian, Amada Rubio Beltran, Antoinette Maassen van den Brink, TM Monticello

Research output: Contribution to journalArticleAcademicpeer-review

23 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)224-238
Number of pages15
JournalRegulatory Toxicology and Pharmacology
Publication statusPublished - 2019

Cite this